...Could single-domain antibody fragments make the difference...
Two vaccines, a single-strain attenuated human RVA (G1[P8]) vaccine (ROTARIX, GlaxoSmithKline Biologicals), and a multi-strain bovine-human reassortant RVA (G1-G4, P1A)8 vaccine (RotaTeq, Merck), are available